James Chao
Directeur/Membre du Conseil chez OptMed, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Alain Klapholz | M | 67 |
OptMed, Inc.
 OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 17 ans |
| Steven B. Sands | M | 65 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 13 ans |
| Martin S. Sands | M | 63 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 13 ans |
| Curtis L. Cetrulo | M | 54 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 2 ans |
| Eddie Island | M | - |
University of California
| - |
| William De La Peña | M | - |
University of California
| - |
| Ervin Braun | M | 69 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 12 ans |
| Kenneth Burhop | M | 71 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 2 ans |
| de la Fuente Veronica | M | - |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
| Barry Sholem | M | 68 |
University of California
| - |
| Kira Stoll | F | - |
University of California
| - |
| Kuo Chuan Tsai | M | - |
University of California
| - |
| Garrett Gomes | M | - |
University of California
| - |
| Rohit Loomba | M | - |
University of California
| - |
| Napoleone Ferrara | M | 67 |
University of California
| - |
| George Marcus | M | 82 |
University of California
| 24 ans |
| Rui Ping Dong | M | 62 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 4 ans |
| Arthur Torres | M | 77 |
University of California
| - |
| Jefferson Coombs | M | - |
University of California
| - |
| Wendell Brase | M | - |
University of California
| - |
| Michael Mussallem | M | 71 |
University of California
| - |
| Edward Holmes | M | 83 |
University of California
| - |
| Rachael Nava | F | - |
University of California
| - |
| Yun Feng Lu | M | 56 |
University of California
| 17 ans |
| Patricia Mizuiri | F | - |
University of California
| - |
| Cathy O'Sullivan | F | - |
University of California
| - |
| Nic Winterstorm | M | - |
University of California
| - |
| Karyn DiGiorgio | F | - |
University of California
| - |
| Gina Fleming | F | - |
University of California
| - |
| Sanjay Jha | M | 60 |
University of California
| - |
| Stephen Brobst | M | - |
University of California
| - |
| Ciaran McArdle | M | - |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
| Jennifer Barnette | F | - |
University of California
| 5 ans |
| Karina Edmonds | M | 53 |
University of California
| - |
| Charles W Tu | M | 72 |
University of California
| 6 ans |
| Burrows H.F. | M | - |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
| Gary May | M | 59 |
University of California
| 7 ans |
| Chalieo Vitoorapakorn | M | 60 |
University of California
| - |
| David S. Lee | M | 87 |
University of California
| - |
| Dara O'Rourke | M | - |
University of California
| - |
| Peter Preuss | M | - |
University of California
| 31 ans |
| George Scangos | M | 76 |
University of California
| - |
| Robert Grant | M | 55 |
University of California
| - |
| Gary Hunt | M | 75 |
University of California
| - |
| Stuart Diamond | M | - |
University of California
| - |
| Paul Wachter | M | 67 |
University of California
| - |
| Kamil Hasan | M | 80 |
University of California
| - |
| Laura Bushnell | F | 56 |
University of California
| - |
| Steve Nataupsky | M | - |
University of California
| - |
| Susan Siegel | F | 63 |
University of California
| - |
| Michael Drake | M | 73 |
University of California
| 4 ans |
| Ronjon Nag | M | 62 |
University of California
| 9 ans |
| Marc Brutten | M | 67 |
University of California
| - |
| Robert Calfee | M | - |
University of California
| - |
| Mark S. Biestman | M | - |
University of California
| - |
| Umesh K. Mishra | M | 66 |
University of California
| 34 ans |
| William A. Gardner | M | - |
University of California
| - |
| Susan Wessler | F | - |
University of California
| - |
| M. T. Clegg | M | - |
University of California
| - |
| James Schurz | M | - |
University of California
| 26 ans |
| Antoni Ribas | M | 58 |
University of California
| - |
| Wei Zong Huang | M | 64 |
University of California
| - |
| Stephen Sherwin | M | 75 |
University of California
| - |
| William M. Pardridge | M | - |
University of California
| - |
| Elizabeth Schaffer | F | - |
University of California
| - |
| Kalyanam Shivkumar | M | 56 |
University of California
| 22 ans |
| Judy Scotchmoor | F | - |
University of California
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Richard Berenson Stone | M | 81 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 68 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- James Chao
- Réseau Personnel
